Correction to: Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature

DOI: https://doi.org/10.1093/noajnl/vdae116
2024-07-08
Abstract:[This corrects the article DOI: 10.1093/noajnl/vdae072.].
What problem does this paper attempt to address?